Sandoz and Pear Therapeutics Launches reSET Medical Mobile APP, for Patients with Substance Use Disorder (SUD)

Shots:

• The launch is in based on the results of study evaluating reSET vs outpatient therapy alone showing improved recovery & abstinence from patients’ substances of abuse with increased retention time
• reSET is a 12 week (90-day) FDA approved, digital cognitive behavioral therapy with medical mobile app for patients aged ≥, used in combination with outpatient clinician-delivered care, offering complete module treatments with face to face therapy sessions
• Companies have also launched support center, reSET Connect Patient Service Center supporting patients to assess reSET app. In April, 2018 Sandoz collaborated with Pear to develop & commercialize reSET for patients with SUD

Click here to read full press release/ article | Ref: Novartis | Image: Mhealth Spot